鼻肠管肠内营养支持在重型颅脑创伤机械通气患者中的应用效果
该研究纳入2015年2月至2017年2月解放军第117医院ICU收治的100例重型颅脑创伤机械通气患者,随机分为鼻胃管组和鼻肠管组各50例。治疗10天后,鼻肠管组血尿素氮和APACHE II评分显著低于鼻胃管组,血红蛋白、白蛋白和GCS评分显著高于鼻胃管组,机械通气时间和住院时间显著短于鼻胃管组,并发症发生率显著低于鼻胃管组。作者认为经鼻肠管行肠内营养有助于此类患者意识恢复、改善营养指标、减少反流误吸等并发症并缩短病程。
要点
- 治疗10天后鼻肠管组血尿素氮低于鼻胃管组(6.3±1.6 mmol/L vs 8.0±2.2 mmol/L,P<0.05)。
- 治疗10天后鼻肠管组白蛋白高于鼻胃管组(35.9±6.2 g/L vs 31.9±6.2 g/L,P<0.05),血红蛋白亦更高(125.9±19.7 g/L vs 113.5±19.6 g/L,P<0.05)。
- 鼻肠管组机械通气时间短于鼻胃管组(14.7±3.4天 vs 17.5±2.9天,P<0.05),住院时间亦更短(15.4±5.6天 vs 19.2±7.3天,P<0.05)。
- 鼻肠管组并发症发生率低于鼻胃管组(10%(5/50)vs 36%(18/50),P<0.05)。
- 治疗10天后鼻肠管组APACHE II评分低于鼻胃管组(17.9±3.2 vs 20.8±6.3,P<0.05),GCS评分高于鼻胃管组(9.7±1.9 vs 8.2±5.7,P<0.05)。
适用人群与场景
- 2015年2月至2017年2月解放军第117医院ICU收治的重型颅脑创伤并接受机械通气的患者,共100例。
处置流程与药物剂量
- 鼻胃管组经鼻胃管行肠内营养,鼻肠管组经鼻空肠喂养管行肠内营养,分组采用随机数字表法,每组50例。
研究设计与关键结果
- 研究类型为随机对照研究,纳入100例重型颅脑创伤机械通气患者,随机分为鼻胃管组和鼻肠管组各50例。
- 治疗前两组血尿素氮、血红蛋白、白蛋白、APACHE II评分和GCS评分差异均无统计学意义。
- 治疗10天后鼻肠管组血尿素氮和APACHE II评分显著低于鼻胃管组(血尿素氮:6.3±1.6 mmol/L vs 8.0±2.2 mmol/L;APACHE II评分:17.9±3.2 vs 20.8±6.3,均P<0.05)。
- 治疗10天后鼻肠管组血红蛋白、白蛋白和GCS评分显著高于鼻胃管组(血红蛋白:125.9±19.7 g/L vs 113.5±19.6 g/L;白蛋白:35.9±6.2 g/L vs 31.9±6.2 g/L;GCS评分:9.7±1.9 vs 8.2±5.7,均P<0.05)。
- 鼻肠管组机械通气时间和住院时间显著短于鼻胃管组(机械通气时间:14.7±3.4天 vs 17.5±2.9天;住院时间:15.4±5.6天 vs 19.2±7.3天,均P<0.05)。
- 鼻肠管组并发症发生率明显低于鼻胃管组(10%(5/50)vs 36%(18/50),P<0.05)。
证据类型、等级与局限
- 证据类型为随机对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对重型颅脑创伤机械通气患者,经鼻肠管行肠内营养有助于意识恢复、改善营养指标、减少反流误吸等并发症并缩短病程,从而明显提高患者生活质量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the effect of indwelling nasointestinal tube for enteral nutrition (EN) support on patients with severe craniocerebral trauma undergoing mechanical ventilation (MV).
METHODS: A total of 100 severe craniocerebral trauma patients undergoing MV admitted to intensive care unit (ICU) of the 117th Hospital of People's Liberation Army from February 2015 to February 2017 were enrolled, and they were divided into nasogastric tube group in which the EN was fed by nasogastric tube and nasal jejunal feeding tube group (nasointestinal tube group) by random digits table, with 50 patients in each group. Blood urea nitrogen (BUN), hemoglobin (Hb), serum albumin (Alb), acute physiology and chronic health evaluation II (APACHE II) score, Glasgow coma scale (GCS) score before and 10 days after treatment, duration of MV, hospitalization time, and the incidences of ventilator-associated pneumonia (VAP) and reflux wrong aspiration of the two groups were observed and compared.
RESULTS: There was no statistically significant difference in BUN, Hb, Alb, APACHE II score or GCS score before treatment between the two groups. Ten days after treatment, BUN and APACHE II score in the nasointestinal tube group were significantly lower than those in the nasogastric tube group [BUN (mmol/L): 6.3±1.6 vs. 8.0±2.2, APACHE II score: 17.9±3.2 vs. 20.8±6.3, both P < 0.05], Hb, Alb, GCS score were significantly higher than those in nasogastric tube group [Hb (g/L): 125.9±19.7 vs. 113.5±19.6, Alb (g/L): 35.9±6.2 vs. 31.9±6.2, GCS score: 9.7±1.9 vs. 8.2±5.7, all P < 0.05], duration of MV and hospitalization time were significantly less than those in the nasogastric tube group [duration of MV (days): 14.7±3.4 vs. 17.5±2.9, hospitalization time (days): 15.4±5.6 vs. 19.2±7.3, both P < 0.05], and the complication rate in nasointestinal tube group was obviously lower than that in nasogastric tube group [10% (5/50) vs. 36% (18/50), P < 0.05].
CONCLUSIONS: For patients with severe craniocerebral trauma treated with MV, the EN treatment by means of indwelling nasointestinal tube is helpful for the recovery of consciousness, improvement of nutritional indexes, reduction of incidences of complications such as reflux aspiration, etc. and shortening the course of disease, thus the method can obviously improve the patients quality of life.
参考来源
- Chen F, Xu C, Zhang C, et al. [Effect of indwelling nasointestinal tube for enteral nutrition support in patients with severe craniocerebral trauma undergoing mechanical ventilation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29308759. doi:10.3760/cma.j.issn.2095-4352.2018.01.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。